<?xml version="1.0" encoding="UTF-8"?>





<rss xmlns:itunes="http://www.itunes.com/DTDs/Podcast-1.0.dtd" version="2.0">


 





 


	









 








	 	 
<channel>
<title>CROI 2016  - CROI 2016</title>
<itunes:author>CROI</itunes:author>
<description>CROI 2016  - CROI 2016: Themed Discussion Sessions</description>
<itunes:summary>CROI 2016  - CROI 2016: Themed Discussion Sessions</itunes:summary>    
<link>http://www.croiconference.org/</link>
<language>en-us</language>
<copyright>Copyright 2016, CROI. All Rights Reserved.</copyright>
<itunes:category>Podcasts</itunes:category>
 
         
<webMaster>support@capitalreach.com</webMaster>
 
        
  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Clinical Pharmacology: Pregnancy, Pediatrics, and Predictions</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29496.mp3?mediaType=feedmp3</link>
<description>
"Themed Discussion Leader" by David M Burger of Radboud University Medical Center, Nijmegen, Netherlands
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29496.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29496.mp3</guid>	
 
<itunes:summary>Themed Discussion: Clinical Pharmacology: Pregnancy, Pediatrics, and Predictions

"Themed Discussion Leader" by David M Burger of Radboud University Medical Center, Nijmegen, Netherlands

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Clinical Pharmacology: Pregnancy, Pediatrics, and Predictions</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29497.mp3?mediaType=feedmp3</link>
<description>
"Dolutegravir Pharmacokinetics in HIV-Infected Pregnant and Postpartum Women" by Nikki Mulligan of University of California San Diego, San Diego, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29497.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29497.mp3</guid>	
 
<itunes:summary>Themed Discussion: Clinical Pharmacology: Pregnancy, Pediatrics, and Predictions

"Dolutegravir Pharmacokinetics in HIV-Infected Pregnant and Postpartum Women" by Nikki Mulligan of University of California San Diego, San Diego, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Clinical Pharmacology: Pregnancy, Pediatrics, and Predictions</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29498.mp3?mediaType=feedmp3</link>
<description>
"Rilpivirine Female Genital Tract Concentrations in Pregnant and Postpartum Women" by Brookie M. Best of University of California San Diego, San Diego, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29498.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29498.mp3</guid>	
 
<itunes:summary>Themed Discussion: Clinical Pharmacology: Pregnancy, Pediatrics, and Predictions

"Rilpivirine Female Genital Tract Concentrations in Pregnant and Postpartum Women" by Brookie M. Best of University of California San Diego, San Diego, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Clinical Pharmacology: Pregnancy, Pediatrics, and Predictions</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29499.mp3?mediaType=feedmp3</link>
<description>
"Nevirapine Dosing for Treatment in the First Month of Life" by Mark Mirochnick of Boston University School of Medicine, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29499.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29499.mp3</guid>	
 
<itunes:summary>Themed Discussion: Clinical Pharmacology: Pregnancy, Pediatrics, and Predictions

"Nevirapine Dosing for Treatment in the First Month of Life" by Mark Mirochnick of Boston University School of Medicine, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Clinical Pharmacology: Pregnancy, Pediatrics, and Predictions</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29500.mp3?mediaType=feedmp3</link>
<description>
"Prediction of Infant Exposure to Maternal Drugs From Breast Milk Using PBPK Modeling" by Adeniyi Olagunju of University of Liverpool, Liverpool, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29500.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29500.mp3</guid>	
 
<itunes:summary>Themed Discussion: Clinical Pharmacology: Pregnancy, Pediatrics, and Predictions

"Prediction of Infant Exposure to Maternal Drugs From Breast Milk Using PBPK Modeling" by Adeniyi Olagunju of University of Liverpool, Liverpool, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Clinical Pharmacology: Pregnancy, Pediatrics, and Predictions</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29501.mp3?mediaType=feedmp3</link>
<description>
"Predicting Utility of Long-Acting Injectables in Paediatric Patients With PBPK Models" by Rajith Kumar Reddy Rajoli of University of Liverpool, Liverpool, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29501.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29501.mp3</guid>	
 
<itunes:summary>Themed Discussion: Clinical Pharmacology: Pregnancy, Pediatrics, and Predictions

"Predicting Utility of Long-Acting Injectables in Paediatric Patients With PBPK Models" by Rajith Kumar Reddy Rajoli of University of Liverpool, Liverpool, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Clinical Pharmacology: Pregnancy, Pediatrics, and Predictions</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29502.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29502.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29502.mp3</guid>	
 
<itunes:summary>Themed Discussion: Clinical Pharmacology: Pregnancy, Pediatrics, and Predictions

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Global Burden and Mortality of Cancer in HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29503.mp3?mediaType=feedmp3</link>
<description>
"Themed Discussion Leader" by William A Blattner of Institute of Human Virology, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29503.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29503.mp3</guid>	
 
<itunes:summary>Themed Discussion: Global Burden and Mortality of Cancer in HIV

"Themed Discussion Leader" by William A Blattner of Institute of Human Virology, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Global Burden and Mortality of Cancer in HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29504.mp3?mediaType=feedmp3</link>
<description>
"Excess Mortality Rates Among HIV-Infected Cancer Patients in the United States" by Anna E. Coghill of National Cancer Institute, Rockville, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29504.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29504.mp3</guid>	
 
<itunes:summary>Themed Discussion: Global Burden and Mortality of Cancer in HIV

"Excess Mortality Rates Among HIV-Infected Cancer Patients in the United States" by Anna E. Coghill of National Cancer Institute, Rockville, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Global Burden and Mortality of Cancer in HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29505.mp3?mediaType=feedmp3</link>
<description>
"Global Burden of Cervical Cancer in HIV-Positive Women on Antiretroviral Therapy" by Eliane Rohner of Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29505.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29505.mp3</guid>	
 
<itunes:summary>Themed Discussion: Global Burden and Mortality of Cancer in HIV

"Global Burden of Cervical Cancer in HIV-Positive Women on Antiretroviral Therapy" by Eliane Rohner of Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Global Burden and Mortality of Cancer in HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29506.mp3?mediaType=feedmp3</link>
<description>
"Risk of Cancer in HIV-Positive Adults on ART in South Africa: A Record Linkage Study" by Mazvita M. Sengayi of National Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29506.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29506.mp3</guid>	
 
<itunes:summary>Themed Discussion: Global Burden and Mortality of Cancer in HIV

"Risk of Cancer in HIV-Positive Adults on ART in South Africa: A Record Linkage Study" by Mazvita M. Sengayi of National Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Global Burden and Mortality of Cancer in HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29507.mp3?mediaType=feedmp3</link>
<description>
"Cancer Versus Tuberculosis Mortality Among HIV-Infected Individuals in Botswana" by Scott Dryden-Peterson of Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29507.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29507.mp3</guid>	
 
<itunes:summary>Themed Discussion: Global Burden and Mortality of Cancer in HIV

"Cancer Versus Tuberculosis Mortality Among HIV-Infected Individuals in Botswana" by Scott Dryden-Peterson of Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Global Burden and Mortality of Cancer in HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29508.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29508.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29508.mp3</guid>	
 
<itunes:summary>Themed Discussion: Global Burden and Mortality of Cancer in HIV

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Rants About HCV RAVS</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29509.mp3?mediaType=feedmp3</link>
<description>
"Themed Discussion Leader" by Gary P. Wang of North Florida/South Georgia Veterans Health System, Gainesville, FL, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29509.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29509.mp3</guid>	
 
<itunes:summary>Themed Discussion: Rants About HCV RAVS

"Themed Discussion Leader" by Gary P. Wang of North Florida/South Georgia Veterans Health System, Gainesville, FL, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Rants About HCV RAVS</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29510.mp3?mediaType=feedmp3</link>
<description>
"Genotypic and Phenotypic Characterization of Clinical HCV NS5A Drug Resistance" by Wei Huang of Monogram Biosciences, South San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29510.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29510.mp3</guid>	
 
<itunes:summary>Themed Discussion: Rants About HCV RAVS

"Genotypic and Phenotypic Characterization of Clinical HCV NS5A Drug Resistance" by Wei Huang of Monogram Biosciences, South San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Rants About HCV RAVS</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29511.mp3?mediaType=feedmp3</link>
<description>
"HCV Resistance to Daclatasvir/Sofosbuvir Across Different Genotypes in the Real Life" by Slim Fourati of INSERM U955, Créteil, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29511.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29511.mp3</guid>	
 
<itunes:summary>Themed Discussion: Rants About HCV RAVS

"HCV Resistance to Daclatasvir/Sofosbuvir Across Different Genotypes in the Real Life" by Slim Fourati of INSERM U955, Créteil, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Rants About HCV RAVS</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29512.mp3?mediaType=feedmp3</link>
<description>
"Tracing the Origin of HCV NS3 Q80K Among HIV-Infected MSM in the Netherlands" by Astrid M. Newsum of Public Health Service of Amsterdam, Amsterdam, Netherlands
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29512.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29512.mp3</guid>	
 
<itunes:summary>Themed Discussion: Rants About HCV RAVS

"Tracing the Origin of HCV NS3 Q80K Among HIV-Infected MSM in the Netherlands" by Astrid M. Newsum of Public Health Service of Amsterdam, Amsterdam, Netherlands

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Rants About HCV RAVS</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29513.mp3?mediaType=feedmp3</link>
<description>
"Polymorphisms at Codon 28 of HCV NS5A Impact NS5A Inhibitor Susceptibility" by Alicia Newton of Monogram Biosciences, South San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29513.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29513.mp3</guid>	
 
<itunes:summary>Themed Discussion: Rants About HCV RAVS

"Polymorphisms at Codon 28 of HCV NS5A Impact NS5A Inhibitor Susceptibility" by Alicia Newton of Monogram Biosciences, South San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Rants About HCV RAVS</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29514.mp3?mediaType=feedmp3</link>
<description>
"Resistance Associated Variants: Data From the NIAID SYNERGY Trial" by Eleanor M.P. Wilson of Institute of Human Virology, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29514.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29514.mp3</guid>	
 
<itunes:summary>Themed Discussion: Rants About HCV RAVS

"Resistance Associated Variants: Data From the NIAID SYNERGY Trial" by Eleanor M.P. Wilson of Institute of Human Virology, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Rants About HCV RAVS</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29515.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29515.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29515.mp3</guid>	
 
<itunes:summary>Themed Discussion: Rants About HCV RAVS

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Learning from Experience: Shaping the Future of Antiretroviral Therapy in Sub-Saharan Africa</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29516.mp3?mediaType=feedmp3</link>
<description>
"Themed Discussion Leader" by Tsitsi Mutasa-Apollo of University of Zimbabwe, Harare, Zimbabwe
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29516.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29516.mp3</guid>	
 
<itunes:summary>Themed Discussion: Learning from Experience: Shaping the Future of Antiretroviral Therapy in Sub-Saharan Africa

"Themed Discussion Leader" by Tsitsi Mutasa-Apollo of University of Zimbabwe, Harare, Zimbabwe

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Learning from Experience: Shaping the Future of Antiretroviral Therapy in Sub-Saharan Africa</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29517.mp3?mediaType=feedmp3</link>
<description>
"6-Year Retention and Immunological Response to ART by Gender: IeDEA West Africa" by Thierry Tiendrebeogo of INSERM U897, Bordeaux, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29517.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29517.mp3</guid>	
 
<itunes:summary>Themed Discussion: Learning from Experience: Shaping the Future of Antiretroviral Therapy in Sub-Saharan Africa

"6-Year Retention and Immunological Response to ART by Gender: IeDEA West Africa" by Thierry Tiendrebeogo of INSERM U897, Bordeaux, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Learning from Experience: Shaping the Future of Antiretroviral Therapy in Sub-Saharan Africa</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29519.mp3?mediaType=feedmp3</link>
<description>
"Comparing Adherence Methods: Which Best Predicts Virological and Resistance Outcome?" by Catherine Orrell of University of Cape Town, Cape Town, South Africa
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29519.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29519.mp3</guid>	
 
<itunes:summary>Themed Discussion: Learning from Experience: Shaping the Future of Antiretroviral Therapy in Sub-Saharan Africa

"Comparing Adherence Methods: Which Best Predicts Virological and Resistance Outcome?" by Catherine Orrell of University of Cape Town, Cape Town, South Africa

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Learning from Experience: Shaping the Future of Antiretroviral Therapy in Sub-Saharan Africa</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29520.mp3?mediaType=feedmp3</link>
<description>
"High Rate of Viral Suppression in Late Mortality on First-Line ART in Uganda/Zimbabwe" by David I. Dolling of Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29520.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29520.mp3</guid>	
 
<itunes:summary>Themed Discussion: Learning from Experience: Shaping the Future of Antiretroviral Therapy in Sub-Saharan Africa

"High Rate of Viral Suppression in Late Mortality on First-Line ART in Uganda/Zimbabwe" by David I. Dolling of Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Learning from Experience: Shaping the Future of Antiretroviral Therapy in Sub-Saharan Africa</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29521.mp3?mediaType=feedmp3</link>
<description>
"Adherence Predicts Failure on PI-Based Second-Line ART in Rural South Africa" by Dami A. Collier of University College London, London, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29521.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29521.mp3</guid>	
 
<itunes:summary>Themed Discussion: Learning from Experience: Shaping the Future of Antiretroviral Therapy in Sub-Saharan Africa

"Adherence Predicts Failure on PI-Based Second-Line ART in Rural South Africa" by Dami A. Collier of University College London, London, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Learning from Experience: Shaping the Future of Antiretroviral Therapy in Sub-Saharan Africa</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29522.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29522.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29522.mp3</guid>	
 
<itunes:summary>Themed Discussion: Learning from Experience: Shaping the Future of Antiretroviral Therapy in Sub-Saharan Africa

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV Testing: A Crucial Foundation</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29523.mp3?mediaType=feedmp3</link>
<description>
"Themed Discussion Leader" by Cheryl Case Johnson of World Health Organization, Geneva, Switzerland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29523.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29523.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV Testing: A Crucial Foundation

"Themed Discussion Leader" by Cheryl Case Johnson of World Health Organization, Geneva, Switzerland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV Testing: A Crucial Foundation</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29524.mp3?mediaType=feedmp3</link>
<description>
"Home-Based HIV Testing and New HIV Diagnoses in Chókwè District, Mozambique" by Isabelle Casavant of Centers for Disease Control and Prevention, Maputo, Mozambique
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29524.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29524.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV Testing: A Crucial Foundation

"Home-Based HIV Testing and New HIV Diagnoses in Chókwè District, Mozambique" by Isabelle Casavant of Centers for Disease Control and Prevention, Maputo, Mozambique

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV Testing: A Crucial Foundation</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29525.mp3?mediaType=feedmp3</link>
<description>
"Home-Based HIV Counseling and Testing Using Index Patients in Lesotho" by Abby L. DiCarlo of ICAP at Columbia University, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29525.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29525.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV Testing: A Crucial Foundation

"Home-Based HIV Counseling and Testing Using Index Patients in Lesotho" by Abby L. DiCarlo of ICAP at Columbia University, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV Testing: A Crucial Foundation</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29526.mp3?mediaType=feedmp3</link>
<description>
"Effective, High-Yield HIV Testing for Partners of Newly Diagnosed Persons in Tanzania" by Marya Plotkin of Jhpiego, Chapel Hill, NC, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29526.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29526.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV Testing: A Crucial Foundation

"Effective, High-Yield HIV Testing for Partners of Newly Diagnosed Persons in Tanzania" by Marya Plotkin of Jhpiego, Chapel Hill, NC, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV Testing: A Crucial Foundation</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29527.mp3?mediaType=feedmp3</link>
<description>
"HIV Testing and Linkage to Care in the Botswana Combination Prevention Project" by Jan S. Moore of Centers for Disease Control and Prevention, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29527.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29527.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV Testing: A Crucial Foundation

"HIV Testing and Linkage to Care in the Botswana Combination Prevention Project" by Jan S. Moore of Centers for Disease Control and Prevention, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV Testing: A Crucial Foundation</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29528.mp3?mediaType=feedmp3</link>
<description>
"94% Population HIV Testing Coverage With Repeat Hybrid Mobile Testing in East Africa" by Gabriel Chamie of University of California San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29528.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29528.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV Testing: A Crucial Foundation

"94% Population HIV Testing Coverage With Repeat Hybrid Mobile Testing in East Africa" by Gabriel Chamie of University of California San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV Testing: A Crucial Foundation</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29529.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29529.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29529.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV Testing: A Crucial Foundation

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV Persistence and Latency Reversal</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29530.mp3?mediaType=feedmp3</link>
<description>
"Themed Discussion Leader" by Sharon R Lewin of Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29530.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29530.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV Persistence and Latency Reversal

"Themed Discussion Leader" by Sharon R Lewin of Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV Persistence and Latency Reversal</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29531.mp3?mediaType=feedmp3</link>
<description>
"Naïve CD4+ T Cells Harbor a Large Inducible Reservoir of Latent HIV-1" by Jennifer M. Zerbato of University of Pittsburgh, Pittsburgh, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29531.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29531.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV Persistence and Latency Reversal

"Naïve CD4+ T Cells Harbor a Large Inducible Reservoir of Latent HIV-1" by Jennifer M. Zerbato of University of Pittsburgh, Pittsburgh, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV Persistence and Latency Reversal</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29532.mp3?mediaType=feedmp3</link>
<description>
"Follicular Tregs Reduce HIV Replication and Reactivation From Latency Ex Vivo" by Brodie Miles of University of Colorado, Denver, CO, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29532.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29532.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV Persistence and Latency Reversal

"Follicular Tregs Reduce HIV Replication and Reactivation From Latency Ex Vivo" by Brodie Miles of University of Colorado, Denver, CO, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV Persistence and Latency Reversal</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29533.mp3?mediaType=feedmp3</link>
<description>
"Dendritic Cell-T-Cell Culture Facilitates HIV Latency in Proliferating CD4+ T Cells" by Nitasha A. Kumar of Emory University, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29533.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29533.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV Persistence and Latency Reversal

"Dendritic Cell-T-Cell Culture Facilitates HIV Latency in Proliferating CD4+ T Cells" by Nitasha A. Kumar of Emory University, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV Persistence and Latency Reversal</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29534.mp3?mediaType=feedmp3</link>
<description>
"A Subset of Infectious Proviruses Persist and Expand Following Activation Ex Vivo" by John K. Bui of University of Pittsburgh, Pittsburgh, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29534.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29534.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV Persistence and Latency Reversal

"A Subset of Infectious Proviruses Persist and Expand Following Activation Ex Vivo" by John K. Bui of University of Pittsburgh, Pittsburgh, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV Persistence and Latency Reversal</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29535.mp3?mediaType=feedmp3</link>
<description>
"Transcription of Novel HIV-1 RNA Species in the Setting of Undetectable Virus" by Hiromi Imamichi of National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29535.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29535.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV Persistence and Latency Reversal

"Transcription of Novel HIV-1 RNA Species in the Setting of Undetectable Virus" by Hiromi Imamichi of National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV Persistence and Latency Reversal</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29536.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29536.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29536.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV Persistence and Latency Reversal

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Stroke: Incidence and Risk Factors</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29632.mp3?mediaType=feedmp3</link>
<description>
"Themed Discussion Leader" by Richard W Price of University of California San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29632.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29632.mp3</guid>	
 
<itunes:summary>Themed Discussion: Stroke: Incidence and Risk Factors

"Themed Discussion Leader" by Richard W Price of University of California San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Stroke: Incidence and Risk Factors</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29633.mp3?mediaType=feedmp3</link>
<description>
"Design, Implementation, and Findings of Next-Generation Stroke Adjudication in HIV" by Heidi M. Crane of University of Washington, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29633.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29633.mp3</guid>	
 
<itunes:summary>Themed Discussion: Stroke: Incidence and Risk Factors

"Design, Implementation, and Findings of Next-Generation Stroke Adjudication in HIV" by Heidi M. Crane of University of Washington, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Stroke: Incidence and Risk Factors</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29634.mp3?mediaType=feedmp3</link>
<description>
"Differences in Predictors for Ischaemic and Haemorrhagic Strokes in HIV+ Individuals" by Camilla I. Hatleberg of Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29634.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29634.mp3</guid>	
 
<itunes:summary>Themed Discussion: Stroke: Incidence and Risk Factors

"Differences in Predictors for Ischaemic and Haemorrhagic Strokes in HIV+ Individuals" by Camilla I. Hatleberg of Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Stroke: Incidence and Risk Factors</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29635.mp3?mediaType=feedmp3</link>
<description>
"Persistently Increased Ischemic Stroke Risk in HIV-Infected Women" by Felicia Chow of University of California San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29635.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29635.mp3</guid>	
 
<itunes:summary>Themed Discussion: Stroke: Incidence and Risk Factors

"Persistently Increased Ischemic Stroke Risk in HIV-Infected Women" by Felicia Chow of University of California San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Stroke: Incidence and Risk Factors</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29636.mp3?mediaType=feedmp3</link>
<description>
"Stroke in HIV-Infected Patients in the Combination Antiretroviral Therapy Era" by Juan Berenguer of Hospital General Universitario Gregorio Marañón, Madrid, Spain
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29636.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29636.mp3</guid>	
 
<itunes:summary>Themed Discussion: Stroke: Incidence and Risk Factors

"Stroke in HIV-Infected Patients in the Combination Antiretroviral Therapy Era" by Juan Berenguer of Hospital General Universitario Gregorio Marañón, Madrid, Spain

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Stroke: Incidence and Risk Factors</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29637.mp3?mediaType=feedmp3</link>
<description>
"Incidental Carotid Plaque in HIV is Associated With Subsequent Cerebrovascular Events" by Sumbal A. Janjua of Massachusetts General Hospital, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29637.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29637.mp3</guid>	
 
<itunes:summary>Themed Discussion: Stroke: Incidence and Risk Factors

"Incidental Carotid Plaque in HIV is Associated With Subsequent Cerebrovascular Events" by Sumbal A. Janjua of Massachusetts General Hospital, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Stroke: Incidence and Risk Factors</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29638.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29638.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29638.mp3</guid>	
 
<itunes:summary>Themed Discussion: Stroke: Incidence and Risk Factors

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV and Microbiomes</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29639.mp3?mediaType=feedmp3</link>
<description>
"Themed Discussion Leader" by Nichole Klatt of University of Washington, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29639.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29639.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV and Microbiomes

"Themed Discussion Leader" by Nichole Klatt of University of Washington, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV and Microbiomes</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29640.mp3?mediaType=feedmp3</link>
<description>
"Distinct Gut Microbiota Composition in Gay Men" by Muntsa Rocafort of IrsiCaixa Institute for AIDS Research, Badalona, Spain
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29640.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29640.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV and Microbiomes

"Distinct Gut Microbiota Composition in Gay Men" by Muntsa Rocafort of IrsiCaixa Institute for AIDS Research, Badalona, Spain

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV and Microbiomes</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29641.mp3?mediaType=feedmp3</link>
<description>
"Impact of HIV-Associated Changes in the Gut Microbiome on Disease Progression" by Jesús M. Luévano of Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29641.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29641.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV and Microbiomes

"Impact of HIV-Associated Changes in the Gut Microbiome on Disease Progression" by Jesús M. Luévano of Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV and Microbiomes</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29642.mp3?mediaType=feedmp3</link>
<description>
"Altered Gut Microbes Enhance Mucosal CD4 T Cell Infection and Depletion Ex Vivo" by Stephanie M. Dillon of University of Colorado Anschutz Medical Campus, Aurora, CO, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29642.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29642.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV and Microbiomes

"Altered Gut Microbes Enhance Mucosal CD4 T Cell Infection and Depletion Ex Vivo" by Stephanie M. Dillon of University of Colorado Anschutz Medical Campus, Aurora, CO, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV and Microbiomes</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29643.mp3?mediaType=feedmp3</link>
<description>
"Enhancement of Microbiota in Macaques Leads to Beneficial Immune Function Modulation" by Jennifer A. Manuzak of University of Washington, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29643.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29643.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV and Microbiomes

"Enhancement of Microbiota in Macaques Leads to Beneficial Immune Function Modulation" by Jennifer A. Manuzak of University of Washington, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV and Microbiomes</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29644.mp3?mediaType=feedmp3</link>
<description>
"Fecal Microbial Transplantation: Safety and Engraftment During Treated HIV Infection" by Ma Somsouk of University of California San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29644.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29644.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV and Microbiomes

"Fecal Microbial Transplantation: Safety and Engraftment During Treated HIV Infection" by Ma Somsouk of University of California San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV and Microbiomes</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29645.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29645.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29645.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV and Microbiomes

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Cryptococcal Disease: Detection and Complications</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29647.mp3?mediaType=feedmp3</link>
<description>
"Maximizing Detection and Improving Outcomes of Cryptococcosis in Rural Tanzania" by Emilio Letang of Swiss Tropical Institute of Public Health, Basel, Switzerland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29647.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29647.mp3</guid>	
 
<itunes:summary>Themed Discussion: Cryptococcal Disease: Detection and Complications

"Maximizing Detection and Improving Outcomes of Cryptococcosis in Rural Tanzania" by Emilio Letang of Swiss Tropical Institute of Public Health, Basel, Switzerland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Cryptococcal Disease: Detection and Complications</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29648.mp3?mediaType=feedmp3</link>
<description>
"Evaluation of Provider-Initiated Cryptococcal Antigen Screening, South Africa" by Nicky Longley of St George's University of London, London, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29648.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29648.mp3</guid>	
 
<itunes:summary>Themed Discussion: Cryptococcal Disease: Detection and Complications

"Evaluation of Provider-Initiated Cryptococcal Antigen Screening, South Africa" by Nicky Longley of St George's University of London, London, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Cryptococcal Disease: Detection and Complications</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29649.mp3?mediaType=feedmp3</link>
<description>
"Immunologic Discrimination of Cryptococcal IRIS From Culture-Positive Relapse" by David R. Boulware of University of Minnesota, Minneapolis, MN, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29649.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29649.mp3</guid>	
 
<itunes:summary>Themed Discussion: Cryptococcal Disease: Detection and Complications

"Immunologic Discrimination of Cryptococcal IRIS From Culture-Positive Relapse" by David R. Boulware of University of Minnesota, Minneapolis, MN, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Cryptococcal Disease: Detection and Complications</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29650.mp3?mediaType=feedmp3</link>
<description>
"Neurocognitive Function in HIV-Infected Persons With Cryptococcal Antigenemia" by Martha P. Montgomery of University of Minnesota, Minneapolis, MN, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29650.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29650.mp3</guid>	
 
<itunes:summary>Themed Discussion: Cryptococcal Disease: Detection and Complications

"Neurocognitive Function in HIV-Infected Persons With Cryptococcal Antigenemia" by Martha P. Montgomery of University of Minnesota, Minneapolis, MN, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Cryptococcal Disease: Detection and Complications</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29651.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29651.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29651.mp3</guid>	
 
<itunes:summary>Themed Discussion: Cryptococcal Disease: Detection and Complications

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: New Drugs for Kids: What's Taking so Long?</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29652.mp3?mediaType=feedmp3</link>
<description>
"Themed Discussion Leader" by Martina Penazzato of World Health Organization, Geneva, Switzerland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29652.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29652.mp3</guid>	
 
<itunes:summary>Themed Discussion: New Drugs for Kids: What's Taking so Long?

"Themed Discussion Leader" by Martina Penazzato of World Health Organization, Geneva, Switzerland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: New Drugs for Kids: What's Taking so Long?</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29653.mp3?mediaType=feedmp3</link>
<description>
"Nevirapine (NVP) Concentrations in HIV-Infected Newborns Receiving Therapeutic Dosing" by Edmund Capparelli of University of California San Diego, San Diego, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29653.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29653.mp3</guid>	
 
<itunes:summary>Themed Discussion: New Drugs for Kids: What's Taking so Long?

"Nevirapine (NVP) Concentrations in HIV-Infected Newborns Receiving Therapeutic Dosing" by Edmund Capparelli of University of California San Diego, San Diego, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: New Drugs for Kids: What's Taking so Long?</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29654.mp3?mediaType=feedmp3</link>
<description>
"IMPAACT 1093: Dolutegravir in 6- to 12-Year-Old HIV-Infected Children: 48-Week Results" by Andrew Wiznia of Albert Einstein College of Medicine, Bronx, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29654.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29654.mp3</guid>	
 
<itunes:summary>Themed Discussion: New Drugs for Kids: What's Taking so Long?

"IMPAACT 1093: Dolutegravir in 6- to 12-Year-Old HIV-Infected Children: 48-Week Results" by Andrew Wiznia of Albert Einstein College of Medicine, Bronx, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: New Drugs for Kids: What's Taking so Long?</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29655.mp3?mediaType=feedmp3</link>
<description>
"Safety and Efficacy of E/C/F/TAF in HIV-1 Infected Treatment-Naïve Adolescents" by Aditya Gaur of St Jude Children's Research Hospital, Memphis, TN, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29655.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29655.mp3</guid>	
 
<itunes:summary>Themed Discussion: New Drugs for Kids: What's Taking so Long?

"Safety and Efficacy of E/C/F/TAF in HIV-1 Infected Treatment-Naïve Adolescents" by Aditya Gaur of St Jude Children's Research Hospital, Memphis, TN, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: New Drugs for Kids: What's Taking so Long?</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29656.mp3?mediaType=feedmp3</link>
<description>
"Pharmacokinetics, Safety, and Efficacy of Maraviroc in Pediatric Patients With R5 HIV" by Carlo Giaquinto of University of Padova, Padova, Italy
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29656.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29656.mp3</guid>	
 
<itunes:summary>Themed Discussion: New Drugs for Kids: What's Taking so Long?

"Pharmacokinetics, Safety, and Efficacy of Maraviroc in Pediatric Patients With R5 HIV" by Carlo Giaquinto of University of Padova, Padova, Italy

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: New Drugs for Kids: What's Taking so Long?</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29657.mp3?mediaType=feedmp3</link>
<description>
"Safety of Tenofovir on Bone Mineral Density in HIV-Infected Youths: A 10-Year Study" by Vania Giacomet of Luigi Sacco Hospital, University of Milan, Milan, Italy
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29657.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29657.mp3</guid>	
 
<itunes:summary>Themed Discussion: New Drugs for Kids: What's Taking so Long?

"Safety of Tenofovir on Bone Mineral Density in HIV-Infected Youths: A 10-Year Study" by Vania Giacomet of Luigi Sacco Hospital, University of Milan, Milan, Italy

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: New Drugs for Kids: What's Taking so Long?</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29658.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29658.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29658.mp3</guid>	
 
<itunes:summary>Themed Discussion: New Drugs for Kids: What's Taking so Long?

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Innovations to Enhance Treatment Outcomes</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29659.mp3?mediaType=feedmp3</link>
<description>
"Themed Discussion Leader" by Moses R. Kamya of Makerere University College of Health Sciences, Kampala, Uganda
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29659.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29659.mp3</guid>	
 
<itunes:summary>Themed Discussion: Innovations to Enhance Treatment Outcomes

"Themed Discussion Leader" by Moses R. Kamya of Makerere University College of Health Sciences, Kampala, Uganda

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Innovations to Enhance Treatment Outcomes</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29660.mp3?mediaType=feedmp3</link>
<description>
"The Real-World Impact of CD4-Eligibility Criteria on Retention in HIV Care" by Jacob Bor of Boston University School of Public Health, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29660.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29660.mp3</guid>	
 
<itunes:summary>Themed Discussion: Innovations to Enhance Treatment Outcomes

"The Real-World Impact of CD4-Eligibility Criteria on Retention in HIV Care" by Jacob Bor of Boston University School of Public Health, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Innovations to Enhance Treatment Outcomes</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29661.mp3?mediaType=feedmp3</link>
<description>
"Do ART Eligibility Expansions Crowd Out the Sickest? Evidence From South Africa" by Sheryl A. Kluberg of Boston University School of Public Health, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29661.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29661.mp3</guid>	
 
<itunes:summary>Themed Discussion: Innovations to Enhance Treatment Outcomes

"Do ART Eligibility Expansions Crowd Out the Sickest? Evidence From South Africa" by Sheryl A. Kluberg of Boston University School of Public Health, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Innovations to Enhance Treatment Outcomes</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29662.mp3?mediaType=feedmp3</link>
<description>
"Evaluating Appointment Patterns to Improve Sustainability of HIV Treatment in Zambia" by Monika Roy of University of California San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29662.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29662.mp3</guid>	
 
<itunes:summary>Themed Discussion: Innovations to Enhance Treatment Outcomes

"Evaluating Appointment Patterns to Improve Sustainability of HIV Treatment in Zambia" by Monika Roy of University of California San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Innovations to Enhance Treatment Outcomes</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29663.mp3?mediaType=feedmp3</link>
<description>
"Outcomes of Patients Enrolled in ART Adherence Clubs After Viral Resuppression" by Joseph T. Sharp of University of Cape Town, Cape Town, South Africa
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29663.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29663.mp3</guid>	
 
<itunes:summary>Themed Discussion: Innovations to Enhance Treatment Outcomes

"Outcomes of Patients Enrolled in ART Adherence Clubs After Viral Resuppression" by Joseph T. Sharp of University of Cape Town, Cape Town, South Africa

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Innovations to Enhance Treatment Outcomes</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29664.mp3?mediaType=feedmp3</link>
<description>
"Barriers to Care and 1-Year Mortality in Newly Diagnosed HIV+ Persons in South Africa" by Ingrid V. Bassett of Massachusetts General Hospital, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29664.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29664.mp3</guid>	
 
<itunes:summary>Themed Discussion: Innovations to Enhance Treatment Outcomes

"Barriers to Care and 1-Year Mortality in Newly Diagnosed HIV+ Persons in South Africa" by Ingrid V. Bassett of Massachusetts General Hospital, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Innovations to Enhance Treatment Outcomes</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29665.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29665.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29665.mp3</guid>	
 
<itunes:summary>Themed Discussion: Innovations to Enhance Treatment Outcomes

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: It's Complicated: Renal Function and STIs in PrEP Users</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29666.mp3?mediaType=feedmp3</link>
<description>
"Themed Discussion Leader" by Amanda Mocroft of University College London, London, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29666.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29666.mp3</guid>	
 
<itunes:summary>Themed Discussion: It's Complicated: Renal Function and STIs in PrEP Users

"Themed Discussion Leader" by Amanda Mocroft of University College London, London, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: It's Complicated: Renal Function and STIs in PrEP Users</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29667.mp3?mediaType=feedmp3</link>
<description>
"Higher Cumulative TFV/FTC Levels in PrEP Associated With Decline in Renal Function" by Monica Gandhi of University of California San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29667.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29667.mp3</guid>	
 
<itunes:summary>Themed Discussion: It's Complicated: Renal Function and STIs in PrEP Users

"Higher Cumulative TFV/FTC Levels in PrEP Associated With Decline in Renal Function" by Monica Gandhi of University of California San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: It's Complicated: Renal Function and STIs in PrEP Users</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29668.mp3?mediaType=feedmp3</link>
<description>
"Changes in Renal Function Associated With TDF/FTC PrEP Use in the US Demo Project" by Albert Y. Liu of San Francisco Department of Public Health, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29668.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29668.mp3</guid>	
 
<itunes:summary>Themed Discussion: It's Complicated: Renal Function and STIs in PrEP Users

"Changes in Renal Function Associated With TDF/FTC PrEP Use in the US Demo Project" by Albert Y. Liu of San Francisco Department of Public Health, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: It's Complicated: Renal Function and STIs in PrEP Users</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29669.mp3?mediaType=feedmp3</link>
<description>
"Rare Incidence of Proximal Tubular Dysfunction With Tenofovir-Based Chemoprophylaxis" by Kenneth K. Mugwanya of University of Washington, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29669.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29669.mp3</guid>	
 
<itunes:summary>Themed Discussion: It's Complicated: Renal Function and STIs in PrEP Users

"Rare Incidence of Proximal Tubular Dysfunction With Tenofovir-Based Chemoprophylaxis" by Kenneth K. Mugwanya of University of Washington, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: It's Complicated: Renal Function and STIs in PrEP Users</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29670.mp3?mediaType=feedmp3</link>
<description>
"STI Data From Community-Based PrEP Implementation Suggest Changes to CDC Guidelines" by Sarit A. Golub of Hunter College and the Graduate Center, City University of New York, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29670.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29670.mp3</guid>	
 
<itunes:summary>Themed Discussion: It's Complicated: Renal Function and STIs in PrEP Users

"STI Data From Community-Based PrEP Implementation Suggest Changes to CDC Guidelines" by Sarit A. Golub of Hunter College and the Graduate Center, City University of New York, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: It's Complicated: Renal Function and STIs in PrEP Users</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29671.mp3?mediaType=feedmp3</link>
<description>
"Quarterly STI Screening Optimizes STI Detection Among PrEP Users in the Demo Project" by Stephanie Cohen of San Francisco Department of Public Health, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29671.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29671.mp3</guid>	
 
<itunes:summary>Themed Discussion: It's Complicated: Renal Function and STIs in PrEP Users

"Quarterly STI Screening Optimizes STI Detection Among PrEP Users in the Demo Project" by Stephanie Cohen of San Francisco Department of Public Health, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: It's Complicated: Renal Function and STIs in PrEP Users</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29672.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29672.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29672.mp3</guid>	
 
<itunes:summary>Themed Discussion: It's Complicated: Renal Function and STIs in PrEP Users

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV Effects on Liver Fibrosis and Steatosis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29751.mp3?mediaType=feedmp3</link>
<description>
"Themed Discussion Leader" by Kenneth E Sherman of University of Cincinnati, Cincinnati, OH, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29751.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29751.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV Effects on Liver Fibrosis and Steatosis

"Themed Discussion Leader" by Kenneth E Sherman of University of Cincinnati, Cincinnati, OH, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV Effects on Liver Fibrosis and Steatosis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29752.mp3?mediaType=feedmp3</link>
<description>
"Poorly Controlled HIV Infection Is a Risk Factor for Liver Fibrosis in CNICS Cohort" by Nina Kim of University of Washington, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29752.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29752.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV Effects on Liver Fibrosis and Steatosis

"Poorly Controlled HIV Infection Is a Risk Factor for Liver Fibrosis in CNICS Cohort" by Nina Kim of University of Washington, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV Effects on Liver Fibrosis and Steatosis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29753.mp3?mediaType=feedmp3</link>
<description>
"Liver Fibrosis in HIV Patients: Which Factors Play a Role?" by Raphael Mohr of University Hospital Bonn, Bonn, Germany
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29753.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29753.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV Effects on Liver Fibrosis and Steatosis

"Liver Fibrosis in HIV Patients: Which Factors Play a Role?" by Raphael Mohr of University Hospital Bonn, Bonn, Germany

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV Effects on Liver Fibrosis and Steatosis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29754.mp3?mediaType=feedmp3</link>
<description>
"Alcohol Use, Hepatitis B, and Liver Fibrosis Among HIV-Infected Persons in West Africa" by Antoine Jaquet of INSERM U897, ISPED, Université de Bordeaux, Bordeaux, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29754.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29754.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV Effects on Liver Fibrosis and Steatosis

"Alcohol Use, Hepatitis B, and Liver Fibrosis Among HIV-Infected Persons in West Africa" by Antoine Jaquet of INSERM U897, ISPED, Université de Bordeaux, Bordeaux, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV Effects on Liver Fibrosis and Steatosis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29755.mp3?mediaType=feedmp3</link>
<description>
"NASH Is Associated With a Unique Biomarker Signature in HIV-Infected Adults" by Rebecca Krakora of National Institutes of Health Clinical Center, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29755.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29755.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV Effects on Liver Fibrosis and Steatosis

"NASH Is Associated With a Unique Biomarker Signature in HIV-Infected Adults" by Rebecca Krakora of National Institutes of Health Clinical Center, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV Effects on Liver Fibrosis and Steatosis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29756.mp3?mediaType=feedmp3</link>
<description>
"Statin Therapy Reduces Liver Fat Measured by Computed Tomography in Patients With HIV" by Janet Lo of Massachusetts General Hospital, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29756.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29756.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV Effects on Liver Fibrosis and Steatosis

"Statin Therapy Reduces Liver Fat Measured by Computed Tomography in Patients With HIV" by Janet Lo of Massachusetts General Hospital, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: HIV Effects on Liver Fibrosis and Steatosis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29757.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29757.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29757.mp3</guid>	
 
<itunes:summary>Themed Discussion: HIV Effects on Liver Fibrosis and Steatosis

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Mind the Gaps: Optimizing the PMTCT Cascade</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29758.mp3?mediaType=feedmp3</link>
<description>
"Themed Discussion Leader" by Marcel Yotebieng of Ohio State University, Columbus, OH, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29758.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29758.mp3</guid>	
 
<itunes:summary>Themed Discussion: Mind the Gaps: Optimizing the PMTCT Cascade

"Themed Discussion Leader" by Marcel Yotebieng of Ohio State University, Columbus, OH, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Mind the Gaps: Optimizing the PMTCT Cascade</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29759.mp3?mediaType=feedmp3</link>
<description>
"Malawi's Option B+ 2011-2015: The Impact of Rapid ART Decentralization" by Sundeep K. Gupta of Centers for Disease Control and Prevention, Lilongwe, Malawi
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29759.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29759.mp3</guid>	
 
<itunes:summary>Themed Discussion: Mind the Gaps: Optimizing the PMTCT Cascade

"Malawi's Option B+ 2011-2015: The Impact of Rapid ART Decentralization" by Sundeep K. Gupta of Centers for Disease Control and Prevention, Lilongwe, Malawi

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Mind the Gaps: Optimizing the PMTCT Cascade</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29760.mp3?mediaType=feedmp3</link>
<description>
"Optimizing PMTCT Outcomes in Rural North-Central Nigeria: A Cluster-Randomized Study" by Muktar H. Aliyu of Vanderbilt Institute for Global Health, Nashville, TN, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29760.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29760.mp3</guid>	
 
<itunes:summary>Themed Discussion: Mind the Gaps: Optimizing the PMTCT Cascade

"Optimizing PMTCT Outcomes in Rural North-Central Nigeria: A Cluster-Randomized Study" by Muktar H. Aliyu of Vanderbilt Institute for Global Health, Nashville, TN, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Mind the Gaps: Optimizing the PMTCT Cascade</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29761.mp3?mediaType=feedmp3</link>
<description>
"Randomized Trial of a Lay Counselor-Led Combination Intervention for PMTCT Retention" by Ruby N. Fayorsey of ICAP, Columbia University Mailman School of Public Health, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29761.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29761.mp3</guid>	
 
<itunes:summary>Themed Discussion: Mind the Gaps: Optimizing the PMTCT Cascade

"Randomized Trial of a Lay Counselor-Led Combination Intervention for PMTCT Retention" by Ruby N. Fayorsey of ICAP, Columbia University Mailman School of Public Health, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Mind the Gaps: Optimizing the PMTCT Cascade</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29762.mp3?mediaType=feedmp3</link>
<description>
"Continuity of Care Among Pregnant Women Lost to Follow-up After Initiating ART" by Kate Clouse of Vanderbilt Institute for Global Health, Nashville, TN, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29762.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29762.mp3</guid>	
 
<itunes:summary>Themed Discussion: Mind the Gaps: Optimizing the PMTCT Cascade

"Continuity of Care Among Pregnant Women Lost to Follow-up After Initiating ART" by Kate Clouse of Vanderbilt Institute for Global Health, Nashville, TN, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Mind the Gaps: Optimizing the PMTCT Cascade</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29763.mp3?mediaType=feedmp3</link>
<description>
"Disclosure and Knowledge Are Associated With Retention in Malawi's Option B+ Program" by Risa M. Hoffman of University of California Los Angeles, Los Angeles, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29763.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29763.mp3</guid>	
 
<itunes:summary>Themed Discussion: Mind the Gaps: Optimizing the PMTCT Cascade

"Disclosure and Knowledge Are Associated With Retention in Malawi's Option B+ Program" by Risa M. Hoffman of University of California Los Angeles, Los Angeles, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Mind the Gaps: Optimizing the PMTCT Cascade</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29764.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29764.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29764.mp3</guid>	
 
<itunes:summary>Themed Discussion: Mind the Gaps: Optimizing the PMTCT Cascade

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Pathways to Eliciting Antibody Responses</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29765.mp3?mediaType=feedmp3</link>
<description>
"Themed Discussion Leader" by Michael Seaman of Harvard Medical School, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29765.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29765.mp3</guid>	
 
<itunes:summary>Themed Discussion: Pathways to Eliciting Antibody Responses

"Themed Discussion Leader" by Michael Seaman of Harvard Medical School, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Pathways to Eliciting Antibody Responses</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29766.mp3?mediaType=feedmp3</link>
<description>
"Oral PrEP Enhances Genital HIV-Neutralizing IgA in HIV-1 Exposed Seronegative Women" by Jairam R. Lingappa of University of Washington, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29766.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29766.mp3</guid>	
 
<itunes:summary>Themed Discussion: Pathways to Eliciting Antibody Responses

"Oral PrEP Enhances Genital HIV-Neutralizing IgA in HIV-1 Exposed Seronegative Women" by Jairam R. Lingappa of University of Washington, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Pathways to Eliciting Antibody Responses</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29767.mp3?mediaType=feedmp3</link>
<description>
"Potent Broadly Neutralising Antibody Responses in Slow-Progressing Pediatric HIV" by Emily Adland of University of Oxford, Oxford, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29767.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29767.mp3</guid>	
 
<itunes:summary>Themed Discussion: Pathways to Eliciting Antibody Responses

"Potent Broadly Neutralising Antibody Responses in Slow-Progressing Pediatric HIV" by Emily Adland of University of Oxford, Oxford, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Pathways to Eliciting Antibody Responses</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29768.mp3?mediaType=feedmp3</link>
<description>
"Broadly Reactive Neutralizing Activity Within the First 6 Months of HIV-1 Infection" by Amanda Fabra García of Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29768.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29768.mp3</guid>	
 
<itunes:summary>Themed Discussion: Pathways to Eliciting Antibody Responses

"Broadly Reactive Neutralizing Activity Within the First 6 Months of HIV-1 Infection" by Amanda Fabra García of Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Pathways to Eliciting Antibody Responses</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29769.mp3?mediaType=feedmp3</link>
<description>
"Immunogenicity and Efficacy of ALVAC-HIV/gp120-Clade C in Alum Regimen in Macaques" by Luca Schifanella of National Institutes of Health, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29769.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29769.mp3</guid>	
 
<itunes:summary>Themed Discussion: Pathways to Eliciting Antibody Responses

"Immunogenicity and Efficacy of ALVAC-HIV/gp120-Clade C in Alum Regimen in Macaques" by Luca Schifanella of National Institutes of Health, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Pathways to Eliciting Antibody Responses</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29770.mp3?mediaType=feedmp3</link>
<description>
"Specific IgG Subclasses Induced in RV305, a Late Boost Vaccination of RV144 Subjects" by Siriwat Akapirat of Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29770.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29770.mp3</guid>	
 
<itunes:summary>Themed Discussion: Pathways to Eliciting Antibody Responses

"Specific IgG Subclasses Induced in RV305, a Late Boost Vaccination of RV144 Subjects" by Siriwat Akapirat of Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Pathways to Eliciting Antibody Responses</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29771.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29771.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29771.mp3</guid>	
 
<itunes:summary>Themed Discussion: Pathways to Eliciting Antibody Responses

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Going to Scale With ART and PrEP</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29772.mp3?mediaType=feedmp3</link>
<description>
"Themed Discussion Leader" by Anne Cori of Imperial College London, London, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29772.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29772.mp3</guid>	
 
<itunes:summary>Themed Discussion: Going to Scale With ART and PrEP

"Themed Discussion Leader" by Anne Cori of Imperial College London, London, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Going to Scale With ART and PrEP</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29773.mp3?mediaType=feedmp3</link>
<description>
"Effect of Eliminating CD4 Thresholds on Number of New  ART Initiators in South Africa" by Jacob Bor of Boston University School of Public Health, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29773.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29773.mp3</guid>	
 
<itunes:summary>Themed Discussion: Going to Scale With ART and PrEP

"Effect of Eliminating CD4 Thresholds on Number of New  ART Initiators in South Africa" by Jacob Bor of Boston University School of Public Health, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Going to Scale With ART and PrEP</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29774.mp3?mediaType=feedmp3</link>
<description>
"Optimizing Resource Allocation to Reduce HIV Incidence Across Sub-Saharan Africa" by Jessica B. McGillen of Imperial College London, London, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29774.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29774.mp3</guid>	
 
<itunes:summary>Themed Discussion: Going to Scale With ART and PrEP

"Optimizing Resource Allocation to Reduce HIV Incidence Across Sub-Saharan Africa" by Jessica B. McGillen of Imperial College London, London, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Going to Scale With ART and PrEP</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29775.mp3?mediaType=feedmp3</link>
<description>
"New ARVs Could Represent More Than USD 3 Billion in Cost Savings Through 2025" by Vineet R. Prabhu of Clinton Health Access Initiative, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29775.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29775.mp3</guid>	
 
<itunes:summary>Themed Discussion: Going to Scale With ART and PrEP

"New ARVs Could Represent More Than USD 3 Billion in Cost Savings Through 2025" by Vineet R. Prabhu of Clinton Health Access Initiative, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Going to Scale With ART and PrEP</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29776.mp3?mediaType=feedmp3</link>
<description>
"Impact of Improving HIV Care and Treatment and Initiating PrEP in the US, 2015-2020" by Emine Yaylali of Centers for Disease Control and Prevention, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29776.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29776.mp3</guid>	
 
<itunes:summary>Themed Discussion: Going to Scale With ART and PrEP

"Impact of Improving HIV Care and Treatment and Initiating PrEP in the US, 2015-2020" by Emine Yaylali of Centers for Disease Control and Prevention, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Going to Scale With ART and PrEP</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29777.mp3?mediaType=feedmp3</link>
<description>
"PrEP Is Only Cost-Effective Among MSM in the Netherlands When Used on Demand" by Brooke E. Nichols of Erasmus University Medical Center, Rotterdam, Netherlands
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29777.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29777.mp3</guid>	
 
<itunes:summary>Themed Discussion: Going to Scale With ART and PrEP

"PrEP Is Only Cost-Effective Among MSM in the Netherlands When Used on Demand" by Brooke E. Nichols of Erasmus University Medical Center, Rotterdam, Netherlands

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Going to Scale With ART and PrEP</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29778.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29778.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29778.mp3</guid>	
 
<itunes:summary>Themed Discussion: Going to Scale With ART and PrEP

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: MSM in Low- and Middle- Income Countries</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29779.mp3?mediaType=feedmp3</link>
<description>
"Themed Discussion Leader" by Adrian D Smith of Nuffield Department of Population Health, Oxford University, Oxford, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29779.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29779.mp3</guid>	
 
<itunes:summary>Themed Discussion: MSM in Low- and Middle- Income Countries

"Themed Discussion Leader" by Adrian D Smith of Nuffield Department of Population Health, Oxford University, Oxford, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: MSM in Low- and Middle- Income Countries</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29780.mp3?mediaType=feedmp3</link>
<description>
"HIV Prevalence and Risk Factors in Men Who Have Sex With Men in Bamako, Mali" by Maria Lahuerta of ICAP at Columbia University, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29780.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29780.mp3</guid>	
 
<itunes:summary>Themed Discussion: MSM in Low- and Middle- Income Countries

"HIV Prevalence and Risk Factors in Men Who Have Sex With Men in Bamako, Mali" by Maria Lahuerta of ICAP at Columbia University, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: MSM in Low- and Middle- Income Countries</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29781.mp3?mediaType=feedmp3</link>
<description>
"Online Sex-Seeking Among MSM in Nigeria: Implications for Online Intervention" by Shauna Stahlman of Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29781.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29781.mp3</guid>	
 
<itunes:summary>Themed Discussion: MSM in Low- and Middle- Income Countries

"Online Sex-Seeking Among MSM in Nigeria: Implications for Online Intervention" by Shauna Stahlman of Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: MSM in Low- and Middle- Income Countries</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29782.mp3?mediaType=feedmp3</link>
<description>
"Group Sex: A Cross-Sectional Online Survey Among Men Who Have Sex With Men in China" by Songyuan Tang of University of North Carolina Project China, Guangzhou, China
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29782.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29782.mp3</guid>	
 
<itunes:summary>Themed Discussion: MSM in Low- and Middle- Income Countries

"Group Sex: A Cross-Sectional Online Survey Among Men Who Have Sex With Men in China" by Songyuan Tang of University of North Carolina Project China, Guangzhou, China

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: MSM in Low- and Middle- Income Countries</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29783.mp3?mediaType=feedmp3</link>
<description>
"Risk Factors for Acute and Early HIV Infection Among MSM, Bangkok,Thailand 2010-2015" by Timothy H. Holtz of Centers for Disease Control and Prevention, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29783.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29783.mp3</guid>	
 
<itunes:summary>Themed Discussion: MSM in Low- and Middle- Income Countries

"Risk Factors for Acute and Early HIV Infection Among MSM, Bangkok,Thailand 2010-2015" by Timothy H. Holtz of Centers for Disease Control and Prevention, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: MSM in Low- and Middle- Income Countries</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29784.mp3?mediaType=feedmp3</link>
<description>
"High Prevalence of HIV Among Wives of Married Men Who Have Sex With Men in India" by Sunil S. Solomon of Johns Hopkins University, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29784.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29784.mp3</guid>	
 
<itunes:summary>Themed Discussion: MSM in Low- and Middle- Income Countries

"High Prevalence of HIV Among Wives of Married Men Who Have Sex With Men in India" by Sunil S. Solomon of Johns Hopkins University, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: MSM in Low- and Middle- Income Countries</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29785.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29785.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29785.mp3</guid>	
 
<itunes:summary>Themed Discussion: MSM in Low- and Middle- Income Countries

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Next Generation Sequencing for Detection of Transmitted or Linked Drug Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29786.mp3?mediaType=feedmp3</link>
<description>
"Themed Discussion Leader" by Jeffrey A. Johnson of Centers for Disease Control and Prevention, Atlanta, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29786.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29786.mp3</guid>	
 
<itunes:summary>Themed Discussion: Next Generation Sequencing for Detection of Transmitted or Linked Drug Resistance

"Themed Discussion Leader" by Jeffrey A. Johnson of Centers for Disease Control and Prevention, Atlanta, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Next Generation Sequencing for Detection of Transmitted or Linked Drug Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29787.mp3?mediaType=feedmp3</link>
<description>
"No Evidence of Sexual Transmission of Minority HIV Drug Resistance Mutations in MSM" by Antoine Chaillon of University of California San Diego, San Diego, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29787.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29787.mp3</guid>	
 
<itunes:summary>Themed Discussion: Next Generation Sequencing for Detection of Transmitted or Linked Drug Resistance

"No Evidence of Sexual Transmission of Minority HIV Drug Resistance Mutations in MSM" by Antoine Chaillon of University of California San Diego, San Diego, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Next Generation Sequencing for Detection of Transmitted or Linked Drug Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29788.mp3?mediaType=feedmp3</link>
<description>
"Transmitted Drug Resistance in HIV-1 Subtype C Hyperacute Infection" by Urisha Singh of University of KwaZulu-Natal, Durban, South Africa
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29788.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29788.mp3</guid>	
 
<itunes:summary>Themed Discussion: Next Generation Sequencing for Detection of Transmitted or Linked Drug Resistance

"Transmitted Drug Resistance in HIV-1 Subtype C Hyperacute Infection" by Urisha Singh of University of KwaZulu-Natal, Durban, South Africa

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Next Generation Sequencing for Detection of Transmitted or Linked Drug Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29789.mp3?mediaType=feedmp3</link>
<description>
"Integrase Inhibitors-Transmitted Drug Resistance Detected by UltraDeep Sequencing" by Eve Todesco of Sorbonne Universités, Paris, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29789.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29789.mp3</guid>	
 
<itunes:summary>Themed Discussion: Next Generation Sequencing for Detection of Transmitted or Linked Drug Resistance

"Integrase Inhibitors-Transmitted Drug Resistance Detected by UltraDeep Sequencing" by Eve Todesco of Sorbonne Universités, Paris, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Next Generation Sequencing for Detection of Transmitted or Linked Drug Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29790.mp3?mediaType=feedmp3</link>
<description>
"Linkage of Rare Drug Resistance Mutations Detected by New Ultrasensitive SGS" by Valerie F. Boltz of National Cancer Institute, Frederick, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29790.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29790.mp3</guid>	
 
<itunes:summary>Themed Discussion: Next Generation Sequencing for Detection of Transmitted or Linked Drug Resistance

"Linkage of Rare Drug Resistance Mutations Detected by New Ultrasensitive SGS" by Valerie F. Boltz of National Cancer Institute, Frederick, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Next Generation Sequencing for Detection of Transmitted or Linked Drug Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/29791.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/29791.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/29791.mp3</guid>	
 
<itunes:summary>Themed Discussion: Next Generation Sequencing for Detection of Transmitted or Linked Drug Resistance

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


	
 
</channel>
</rss>
